In 2014, the FDA approved semaglutide (ozempic) for type 2 diabetes
Semaglutide can be used with other diabetes medications, but it requires careful management by your doctor
Safety Profile of Oral Semaglutide As a result of the stimulation of GLP-1 receptors in the GI tract, semaglutide may directly influence GI motility, secretion, and sensitivity, contributing to GI symptoms such as nausea, vomiting, diarrhea or constipation, and abdominal discomfort
At Reliable MD, we provide Semaglutide GLP-1 as an effective weight loss solution
Details regarding the neurocognitive effects of semaglutide are shown in Table 2 and studies addressing the mental health aspects of semaglutide are listed in Table 3